Researchers from the University of Central Florida recently received a $400,000 grant from the Juvenile Diabetes Research Foundation, which they will use to create a tube that resists infection and encapsulation and is inserted under the skin for the delivery of insulin via a pump.
Featured
Industry News NOVARTIS CORPORATION: Novartis announces FDA approval of Gilenya® as the first disease-modifying therapy for pediatric relapsing multiple sclerosis
Latest News
Industry News THERAVANCE BIOPHARMA: Theravance Biopharma and Mylan Expand YUPELRI® (revefenacin) Development and Commercialization Agreement to Include China and Adjacent Territories
.jpg){kind=tracking}
Industry News BANNER HEALTH: Banner Health addressing drug shortages through Premier's ProvideGx™ generics sourcing subsidiary
Federal Issues
AQUESTIVE THERAPEUTICS: Granted Temporary Restraining Order (TRO) Against Alvogen
- PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION: PCMA Supports Legislation to Ensure Patients Pay Lowest Price for Prescription Drugs
- U.S. DEPARTMENT OF HOMELAND SECURITY: DHS Statement on Protecting the Nation from Foreign Terrorist Entry to the United States
- PHARMACEUTICAL CARE MANAGEMENT CARE ASSOCIATION: Federal Circuit Court Unanimously Strikes Down Arkansas Mandate Restricting PBM Tools
- PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION: Congressional Budget Office Score of Medicare Point-of-Sale Rebates Undermines Drugmakers’ Signature Issue
Industry News
- REGENERON PHARMACEUTICALS, INC.: Regeneron CD20xCD3 Bispecific REGN1979 Shows Positive Results in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma, including in CAR-T Failures
- TITAN PHARMACEUTICALS: Titan Pharmaceuticals Partners With Southside To Further Expand Specialty Pharmacy Network For Probuphine®
- BANNER HEALTH: Banner Health addressing drug shortages through Premier's ProvideGx™ generics sourcing subsidiary
- GOOD SHEPHERD PHARMACY: Nonprofit Pharmacy, University Establish Blockchain Consortium To Reclaim Medicines And Track Prescription Waste
Innovation
- SALIC PHARMACEUTICALS: Launches National Initiatives Aimed At Improving Recognition Of IBS Symptoms, Early Diagnosis And Treatment
- SANOFI: FDA expands indication for Soliqua® 100/33
- DIAGNOSTIC SOLUTIONS LABORATORY: Revolutionizes Precision Medicine with GenomicInsight™ Genomic Health Profile Powered by Opus23 Explorer™
- CANNABICS PHARMACEUTICALS INC.: Cannabics Pharmaceuticals and Wize Pharma to Form Joint Venture to Develop Cannabinoid Based Ophthalmic Therapeutics
Regulatory
- AMERISOURCE BERGEN: US Bioservices Selected by Biocodex SAS to Exclusively Dispense DIACOMIT® (stiripentol)
- JAZZ PHARMACEUTICALS: Announces U.S. FDA Approval of Sunosi™ (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
- SAREPTA THERAPEUTICS, INC.: Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
- SANOFI: FDA approves Cablivi® (caplacizumab-yhdp), the first Nanobody®-based medicine, for adults with acquired thrombotic thrombocytopenic purpura (aTTP)
Alerts Sign-up